Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 9661609)

Published in J Clin Endocrinol Metab on July 01, 1998

Authors

B Imani1, M J Eijkemans, E R te Velde, J D Habbema, B C Fauser

Author Affiliations

1: Department of Obstetrics and Gynecology, University Hospital, Rotterdam, The Netherlands.

Associated clinical trials:

Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS | NCT03316469

Articles citing this

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43

Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol (2013) 1.60

Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial. J Assist Reprod Genet (2013) 1.45

Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene. J Clin Endocrinol Metab (2007) 1.14

The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci (2010) 1.03

Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial. BMJ (2004) 0.99

Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab (2015) 0.96

Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol (2016) 0.90

Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med (2013) 0.84

The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol (2003) 0.82

Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate. Hum Reprod (2008) 0.82

Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins. Hum Reprod (2010) 0.81

Optimal management of subfertility in polycystic ovary syndrome. Int J Womens Health (2014) 0.80

Acupuncture and clomiphene citrate for live birth in polycystic ovary syndrome: study design of a randomized controlled trial. Evid Based Complement Alternat Med (2013) 0.80

Improved responsiveness of PCOS patients to clomiphene after CYP17a inhibitor. J Assist Reprod Genet (2001) 0.79

Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome. J Ovarian Res (2014) 0.77

Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI. Iran J Reprod Med (2011) 0.76

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate. Clin Exp Reprod Med (2016) 0.75

Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome. Int J Fertil Steril (2016) 0.75

The significance of anthropometric and endocrine parameters in ovulation induction with clomiphene citrate in women with polycystic ovary syndrome. Saudi Med J (2016) 0.75

Anovulation and ovulation induction. Hippokratia (2006) 0.75

Bone morphogenetic proteins and the polycystic ovary syndrome. J Ovarian Res (2013) 0.75

Articles by these authors

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol (2001) 10.16

Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol (1999) 6.66

A clinical prediction rule for renal artery stenosis. Ann Intern Med (1998) 4.32

Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst (2000) 3.92

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59

Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med (2000) 3.25

Management of children with acute pharyngitis: a decision analysis. J Fam Pract (1992) 2.75

The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum (1997) 2.56

Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ (1993) 2.48

Ovarian aging: mechanisms and clinical consequences. Endocr Rev (2009) 2.45

Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making (2001) 2.45

Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology (1997) 2.28

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer (1991) 2.18

Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum (1995) 2.15

Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in The Netherlands. Soc Sci Med (1988) 2.11

Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ (1991) 2.09

Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod (2009) 2.03

Twins of mixed races: consequences for Dutch IVF laboratories. Hum Reprod (1997) 2.02

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab (2011) 2.02

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update (2010) 2.01

[Androgens, well-being and libido in women]. Ned Tijdschr Geneeskd (2003) 2.01

Predicting mortality from cervical cancer after negative smear test results. BMJ (1992) 2.01

The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res (1999) 1.98

A model for breast cancer screening. Cancer (1990) 1.96

Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves. Med Decis Making (1997) 1.96

Quantitative studies on the dispersal of skin bacteria into the air. J Med Microbiol (1976) 1.85

The role of genetic factors in age at natural menopause. Hum Reprod (2001) 1.83

Estimating the magnitude of STD cofactor effects on HIV transmission: how well can it be done? Sex Transm Dis (2001) 1.83

Reliability of the diagnosis of a first seizure. Neurology (1989) 1.82

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG (2006) 1.77

The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop (1991) 1.76

Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg (1994) 1.74

Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis. Cancer (1999) 1.71

ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed (1990) 1.70

Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod (2004) 1.70

Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data. Arch Intern Med (1995) 1.70

Fecal incontinence: endoanal US versus endoanal MR imaging. Radiology (1999) 1.65

Regional differences in mortality from conditions amenable to medical intervention in The Netherlands: a comparison of four time periods. J Epidemiol Community Health (1988) 1.64

Pesticide exposure and decreased fertilisation rates in vitro. Lancet (1999) 1.62

Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis (1995) 1.58

Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population. Community Genet (1998) 1.52

Large scale ivermectin distribution and its epidemiological consequences. Acta Leiden (1990) 1.51

Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst (1986) 1.50

Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS (2000) 1.50

The measurement of performance in probabilistic diagnosis. III. Methods based on continuous functions of the diagnostic probabilities. Methods Inf Med (1978) 1.49

Hip fracture in elderly patients: outcomes for function, quality of life, and type of residence. Clin Orthop Relat Res (2001) 1.48

Use of Markov series and Monte Carlo simulation in predicting replacement valve performances. J Heart Valve Dis (1998) 1.47

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon). Fertil Steril (2001) 1.46

Falls in dementia patients. Gerontologist (1993) 1.46

Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears. Am J Clin Pathol (2001) 1.45

Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet (2005) 1.42

[What to do in a 60-year-old HIV-positive woman with a cerebral arteriovenous malformation? Decision analysis]. Ned Tijdschr Geneeskd (1995) 1.40

The validity of the postcoital test for estimating the probability of conceiving. Am J Obstet Gynecol (1994) 1.40

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod (2009) 1.40

Pain and quality of life in patients with critical limb ischaemia: results of a randomized controlled multicentre study on the effect of spinal cord stimulation. ESES study group. Eur J Pain (2000) 1.40

Dynamics of ovarian function in an adult woman with McCune--Albright syndrome. J Clin Endocrinol Metab (2001) 1.39

A measure of survival time for long-term follow-up studies of the elderly. J Clin Epidemiol (1989) 1.39

[Serum screening in pregnant women for Down syndrome and open neural-tube defects; testing against the Health Council criteria for genetic screening]. Ned Tijdschr Geneeskd (1996) 1.39

[Role of andrology in the diagnosis and treatment of fertility disorders]. Ned Tijdschr Geneeskd (1995) 1.39

The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed (1985) 1.39

The "utility" of the Time Trade-Off method in cancer patients: feasibility and proportional Trade-Off. J Clin Epidemiol (1995) 1.32

GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update (2006) 1.32

Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril (1999) 1.32

Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod (2004) 1.29

Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril (1996) 1.27

Systematic selection of prognostic features in patients with severe head injury. Neurosurgery (1980) 1.27

A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. Eur J Cancer (1995) 1.27

Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J Pediatr (1994) 1.25

Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation. Circulation (2001) 1.24

The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. Bull World Health Organ (1991) 1.24

A pocket chart to estimate true Schistosoma mansoni prevalences. Parasitol Today (1993) 1.23

The 'utility' of the visual analog scale in medical decision making and technology assessment. Is it an alternative to the time trade-off? Int J Technol Assess Health Care (1996) 1.23

A model for variations in single and repeated egg counts in Schistosoma mansoni infections. Parasitology (1992) 1.22

Diagnostic and treatment procedures induced by cervical cancer screening. Eur J Cancer (1990) 1.20

Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture. Fertil Steril (2000) 1.20

Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol Today (2000) 1.19

Estimated event-free life expectancy after autograft aortic root replacement in adults. Ann Thorac Surg (2001) 1.19

A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril (2000) 1.18

Validation of a prediction model and its predictors for the histology of residual masses in nonseminomatous testicular cancer. J Urol (2001) 1.17

Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril (1997) 1.17

Costs of medical care after first-ever stroke in The Netherlands. Stroke (1995) 1.16

The cost-effectiveness of breast cancer screening. Int J Cancer (1989) 1.16

Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1. Thorax (1996) 1.16

The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. J Clin Endocrinol Metab (1998) 1.15

Survival of human ovarian follicles from fetal to adult life: apoptosis, apoptosis-related proteins, and transcription factor GATA-4. J Clin Endocrinol Metab (2001) 1.13

Age thresholds for prophylactic replacement of Björk-Shiley convexo-concave heart valves. A clinical and economic evaluation. Circulation (1993) 1.13